UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042430
Receipt number R000048439
Scientific Title Survey of tomotherapy for methotelioma in Japan: patterns of practice and clinical outcomes.
Date of disclosure of the study information 2020/11/13
Last modified on 2022/05/15 16:03:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Survey of tomotherapy for methotelioma in Japan: patterns of practice and clinical outcomes.

Acronym

Survey of tomotherapy for methotelioma in Japan: patterns of practice and clinical outcomes.

Scientific Title

Survey of tomotherapy for methotelioma in Japan: patterns of practice and clinical outcomes.

Scientific Title:Acronym

Survey of tomotherapy for methotelioma in Japan: patterns of practice and clinical outcomes.

Region

Japan


Condition

Condition

Malignant pleural mesothelioma

Classification by specialty

Chest surgery Radiology Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

There are few reports of malignant pleural mesothelioma due to its frequency in Japan. In addition, the radiation treatment plan is considered to be heterogeneous in individual cases at the tumor site and at-risk organs. The purpose of this study is to analyze the current status of curative radiation therapy for malignant pleural mesothelioma by tomotherapy and to evaluate the current treatment results in Japan.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Overall survival

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Underwent radicak radiation therapy using Tomotherapy (Including combined use of Tomotherapy and Linic).
2. Prescription dose is more tan 45Gy (Including cases did not reach the priscriotion dose).
3. Whether or not the tumor remains after surgery.
4. Whether or not chemotherapy is used in combination.
5. With or without surgical surgery (including preoperative irradiation and no surgery).
6. Stage III or less in TMN stage classification.

Key exclusion criteria

1. Under 20 years of age during radiation therapy.
2. Cases had underwent radiation therapy to the chest
3. Histopathologically undetermined or unconscionable diagnosis

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Taro
Middle name
Last name Murai

Organization

Nagoya City University

Division name

Department of Radiology

Zip code

4678601

Address

1 Kawasumi, Mizuho-cho, Mizuoho-ku,Nagoya-shi,Aichi

TEL

0528538276

Email

taro8864@yahoo.co.jp


Public contact

Name of contact person

1st name Mikiko
Middle name
Last name Imai

Organization

Nagoya City University

Division name

Department of Radiology

Zip code

4678601

Address

1 Kawasumi, Mizuho-cho, Mizuoho-ku,Nagoya-shi,Aichi

TEL

0528538276

Homepage URL


Email

nakanishi.ncu@gmail.com


Sponsor or person

Institute

Nagoya City University
Department of Radiology

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagoya City University Hospital

Address

1 Kawasumi, Mizuho-cho, Mizuoho-ku,Nagoya-shi,Aichi

Tel

0528515511

Email

nakanishi.ncu@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 11 Month 13 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://pubmed.ncbi.nlm.nih.gov/35138408/

Number of participants that the trial has enrolled

31

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 09 Month 20 Day

Date of IRB

2019 Year 11 Month 07 Day

Anticipated trial start date

2019 Year 11 Month 07 Day

Last follow-up date

2021 Year 11 Month 07 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

observational study


Management information

Registered date

2020 Year 11 Month 12 Day

Last modified on

2022 Year 05 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048439


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name